Nucleotide substitution: C?T.
Numbering corresponds to RE02556 sequence.
Amino acid replacement: Q414term.
C21070924T
C?T
Q402term | Iqsec-PA; Q414term | Iqsec-PB; Q299term | Iqsec-PC; Q309term | Iqsec-PD
Q414term
sizT1032-homozygous clonal dorsal multidendritic ddaC neurons within a mosaic individual exhibit no defects in the dendritic arborization at the white pupa stage, nor in pruning at 16h after puparium formation, as compared to controls.
Myoblast fusion is blocked at the bi- and tri-nuclear stage in sizT1032 mutant embryos.
sizT1032 mutants exhibit increased numbers of wild-type sized actin foci, consistent with a block in myoblast fusion. Live imaging of sizT1032 mutants indicates that whereas actin foci form normally, they never dissolve, correlating with the increased numbers of foci observed and a complete fusion block.
In mutant embryos myoblast fusion fails to occur. Fusion competent myoblasts extend filopodia toward elongated founder cells, suggesting that adhesion between fusion-competent myoblasts and founder cells is not affected. Occasionally miniature fibres that contain two nuclei are seen.
IqsecT1032 has fusion competent cell phenotype, enhanceable by Df(3L)BK9
IqsecT1032 has fusion competent cell phenotype, enhanceable by Df(2R)Vrp1D30
IqsecT1032 has fusion competent cell phenotype, enhanceable by blow2
IqsecT1032/siz[+] is an enhancer of ommatidium phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
IqsecT1032/siz[+] is an enhancer of retina phenotype of Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF
IqsecT1032/siz[+] is an enhancer of ommatidium phenotype of Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF
IqsecT1032/siz[+] is an enhancer of primary pigment cell phenotype of Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF
IqsecT1032/siz[+] is an enhancer of secondary pigment cell phenotype of Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF
IqsecT1032/siz[+] is an enhancer of tertiary pigment cell phenotype of Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF
IqsecT1032/siz[+] is an enhancer of cone cell phenotype of Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF
IqsecT1032/siz[+] is an enhancer of interommatidial precursor cell phenotype of Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF
The eye mis-patterning phenotype resulting from the co-expression of Arf51FGD13822 with Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is significantly enhanced in sizT1032 heterozygotes. The number of correctly patterned secondary and tertiary cell is reduced. The total number of interommatidial precursor cells (IPCs) does not differ markedly from the wild-type number of 12, indicating that the enhancement is due to specifically to increased disorder in IPC patterning. Additionally, errors in the placement of three bristle groups about each ommatidium and errors in primary pigment cell and cone cell patterning and ommatidial rotation are modestly enhanced.
The ommatidial patterning errors resulting from the expression of cindrdsRNA.PC.PD.Scer\UAS via Scer\GAL4GMR.PF are strongly enhanced in sizT1032 heterozygotes.
Myoblast fusion is completely blocked in Df(3L)BK9, sizT1032 double mutant embryos. Founders remain mononucleate.
Myoblast fusion is significantly compromised in sizT1032; Df(3L)BK9 double mutants. There is a greater percentage of hemisegments with a reduced number of nuclei in the double mutants than there is in the single mutants.
Myoblast fusion is significantly compromised in blow2; sizT1032 double mutants. There is a greater percentage of hemisegments with a reduced number of nuclei in the double mutants than there is in the single mutants.